Neuraminidase inhibitors for preventing and treating influenza in adults and children

Jefferson, Tom, Jones, Mark A, Doshi, Peter, Del Mar, Chris B, Hama, Rokuro, Thompson, Matthew J, Spencer, Elizabeth A, Onakpoya, Igho J +4 more·2014·Cochrane Database of Systematic Reviews

DOI 10.1002/14651858.cd008965.pub4

Cited by (383)

Items 101–200 of 383

Immune response in influenza virus infection and modulation of immune injury by viral neuraminidase
Hongyu Jiang, Zongde Zhang · 2023 · Virology Journal
The “wicked problems” of governing UK health security disaster prevention
John Connolly · 2015 · Disaster Prevention and Management An International Journal
Continued high incidence of children with severe influenza A(H1N1)pdm09 admitted to paediatric intensive care units in Germany during the first three post-pandemic influenza seasons, 2010/11–2012/13
for the Bavarian PICU Study Group on Influenza and Other Viral ARI, Andrea Streng, Christiane Prifert, Benedikt Weißbrich, Johannes G. Liese · 2015 · BMC Infectious Diseases
The effect of statins on influenza‐like illness morbidity and mortality
Paul Brassard, Jennifer W. Wu, Pierre Ernst, Sophie Dell’Aniello, Brielan Smiechowski, Samy Suissa · 2016 · Pharmacoepidemiology and Drug Safety
Facing the Credibility Crisis of Science: On the Ambivalent Role of Pluralism in Establishing Relevance and Reliability
MARTIN J. CARRIER · 2017 · Perspectives on Science
Insights from respiratory virus co-infections
Vasiliki Epameinondas GEORGAKOPOULOU · 2024 · World Journal of Virology
Non-disclosure of developmental neurotoxicity studies obstructs the safety assessment of pesticides in the European Union
Axel Mie, Christina Rudén · 2023 · Environmental Health
High-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase Activity
Yuuki Kurebayashi, Tadanobu Takahashi, Tamoto Chihiro, Keiji Sahara, Tadamune Otsubo, Tatsuya Yokozawa, Nona Shibahara, Hirohisa Wada, Akira Minami, Kiyoshi Ikeda et al. · 2016 · PLoS ONE
SARS-CoV-2 challenge studies: ethics and risk minimisation
Susan Bull, Euzebiusz Jamrozik, Ariella Binik, Michael James Parker · 2020 · Journal of Medical Ethics
Is viral coinfection a risk factor for severe lower respiratory tract infection? A retrospective observational study
Aykut Eşki, Gökçen Kartal Öztürk, Candan Çiçek, Figen Gülen, Esen Demir · 2021 · Pediatric Pulmonology
Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo
Carolin M. Lieber, Hae‐Ji Kang, Megha Aggarwal, Nicole A. P. Lieberman, Elizabeth B. Sobolik, Jeong-Joong Yoon, Michael G. Natchus, Robert M. Cox, Alexander L. Greninger, Richard Karl Plemper · 2024 · PLoS Pathogens
Amantadine and rimantadine for influenza A in children and the elderly
Márcia G Alves Galvão, Marilene Augusta Rocha Crispino Santos, Antonio JL Alves da Cunha · 2012 · Cochrane Database of Systematic Reviews
Novel Polyanions Inhibiting Replication of Influenza Viruses
Justyna Ciejka, Aleksandra Milewska, Magdalena Wytrwał-Sarna, Jacek Wojarski, Anna Gołda, Marek Ochman, Maria Nowakowska, Krzysztof Szczubiałka, Krzysztof Pyrć · 2016 · Antimicrobial Agents and Chemotherapy
The pharmacological management of severe influenza infection – ‘existing and emerging therapies’
Aisling McMahon, Ignacio Martín‐Loeches · 2016 · Expert Review of Clinical Pharmacology
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review
Chahat Suri, Babita Pande, Lakkakula Suhasini Sahithi, Tarun A Sahu, Henu Kumar Verma · 2024 · Microorganisms
Impact of Oseltamivir Treatment on Influenza A and B Virus Dynamics in Human Volunteers
Kyla L. Hooker, Vitaly V. Ganusov · 2021 · Frontiers in Microbiology
Prescription of anti-influenza drugs in Japan, 2014–2020: A retrospective study using open data from the national claims database
Akahito Sako, Yoshiaki Gu, Yoshinori Masui, Kensuke Yoshimura, Hidekatsu Yanai, Norio Ohmagari · 2023 · PLoS ONE
Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance
Rueshandra Roosenhoff, Erhard van der Vries, Anne van der Linden, Geert van Amerongen, Koert J. Stittelaar, Saskia L. Smits, Martin Schutten, Ron A. M. Fouchier · 2018 · PLoS ONE
Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
Joseph Jonathan Lee, Margaret C Smith, Clare R Bankhead, Rafael Perera, Antonis A. Kousoulis, Christopher Butler, Kay Wang · 2020 · European Respiratory Journal
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018
Samuel Coenen, Alike W. van der Velden, Daniela Cianci, Herman Goossens, Emily Bongard, Benjamin R. Saville, Nina Gobat, Muireann de Paor, Margareta M. Ieven, Theo JM Verheij et al. · 2020 · British Journal of General Practice
Recent Advances in Enzyme Inhibition: A Pharmacological Review
Kuldeep Singh, Bharat Bhushan, Nidhi Mittal, Abhishek Kushwaha, Chandan Kumar Raikwar, Arun Kumar Sharma, Dilip Kumar Chanchal, Shivendra Kumar, Mohit Agrawal · 2023 · Current Enzyme Inhibition
Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol for a systematic review
Evan Mayo‐Wilson, Susan M. Hutfless, Tianjing Li, Gillian K. Gresham, Nicole Fusco, Jeffrey T. Ehmsen, James Heyward, S. Swaroop Vedula, Diana Lock, Jennifer A. Haythornthwaite et al. · 2015 · Systematic Reviews
Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context
Robert G. Moss, James M. McCaw, Allen C. Cheng, Aeron C. Hurt, Jodie McVernon · 2016 · BMC Infectious Diseases
Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada
Patrick Saunders‐Hastings, Bryson Quinn Hayes, Robert J. Smith, Daniel R. Krewski · 2017 · PLoS ONE
Acute Respiratory Viral Infection in Children: Modern Approaches to Diagnosis and Treatment
Baranov Aa, Yu. V. Lobzin, Leyla Seymurovna Namazova-Baranova, Vladimir K. Tatochenko, Alexander N. Uskov, Tatiana V. Kulichenko, M. D. Bakradze, Еlena A. Vishneva, Lilia R. Selimzianova, Anastasia S. Polyakova et al. · 2017 · Педиатрическая фармакология
Qualität 2030. Die umfassende Strategie für das Gesundheitswesen
Matthias Schrappe · 2014 · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks
The effect of neuraminidase inhibitors on household transmission in Japanese patients with influenza A and B infection: A prospective, observational study
Nobuo Hirotsu, Yutaka Saisho, Takahiro Hasegawa · 2018 · Influenza and Other Respiratory Viruses
Which interventions are effective at decreasing or increasing emergency department attendances or hospital admissions from long-term care facilities? A systematic review
Ben Searle, Robert Barker, Daniel Stow, Gemma Spiers, Fiona Pearson, Barbara Hanratty · 2023 · BMJ Open
Beyond confusion and controversy, can we evaluate the real efficacy and safety of cholesterol-lowering with statins?
Michel de Lorgeril, Mikael Rabaeus · 2016 · Journal of Controversies in Biomedical Research
Oseltamivir para el tratamiento de la gripe en niños y adolescentes
Alfredo Tagarro, Marta Cruz-Cañete, Enrique Otheo, Cristian Launes, José Antonio Couceiro, Carlos Pérez, Santiago Alfayate Miguélez, Cristina Calvo, Carlos Rodrigo · 2019 · Anales de Pediatría
Cultural adaptation of two school-based smoking prevention programs in Bogotá, Colombia
Sharon Sánchez-Franco, Luis Fernando Arias, Joaquín Jaramillo, Jennifer Murray, Ruth Fiona Hunter, Blanca Amalia Llorente, Linda Bauld, Sally Good, Judith West, Frank Kee et al. · 2021 · Translational Behavioral Medicine
Interventions for preventing influenza: an overview of Cochrane systematic reviews and a Bayesian network meta-analysis
Yuan, Yi, Wang, Rui-Ting, Xia, Jun, Cao, Hui-Juan · 2021 · Journal of Integrative Medicine
Arbidol for preventing and treating influenza in adults and children
Liang Huang, Lingli Zhang, Yantao Liu, Rong Luo, Linan Zeng, Irina Telegina, Vasily Vlassov · 2017 · Cochrane Database of Systematic Reviews
Accuracy of individual signs and symptoms and case definitions for the diagnosis of influenza in different age groups: a systematic review with meta-analysis
Mark H. Ebell, Ivan Rahmatullah, Cassie Hulme, Michelle Buhr, Jack Henry Kotnik, Rachel E. Geyer, Matthew Thompson, Barry R. Lutz · 2025 · BMJ Open
Research gaps in the philosophy of evidence‐based medicine
Alexander Mebius, Ashley Graham Kennedy, Jeremy Howick · 2016 · Philosophy Compass
Oseltamivir for the treatment of influenza in children and adolescents
Alfredo Tagarro, Marta Cruz-Cañete, Enrique Otheo, Cristian Launes, José Antonio Couceiro, Carlos Pérez, Santiago Alfayate, Cristina Calvo, Carlos Rodrigo · 2019 · Anales de Pediatría (English Edition)
How to protect long-term care facilities from pandemic-like events? - A systematic review on the effectiveness of non-pharmacological measures to prevent viral respiratory infections
Laura Arnold, Simon Bimczok, Hannah Schütt, Stefanie Lisak-Wahl, Barbara Buchberger, Jan M Stratil · 2024 · BMC Infectious Diseases
Point-of-care and Home Use Influenza Diagnostics for Advancing Therapeutic and Public Health Strategies
Gregory L. Damhorst, Wilbur Aaron Lam · 2025 · The Journal of Infectious Diseases
Fluctuations in influenza-like illness epidemics and suicide mortality: A time-series regression of 13-year mortality data in South Korea
Sun Jae Jung, Sung‐Shil Lim, Jin‐Ha Yoon · 2021 · PLoS ONE
Practical prevention of nosocomial influenza transmission, ‘a hierarchical control’ issue
Frank O’Reilly, Gayle P. Dolan, Jonathan S. Nguyen‐Van‐Tam, Peter A Noone · 2015 · Occupational Medicine
Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit
Mimi Yue, Joel T Collins, Elango Subramoniapillai, Glen Kennedy · 2016 · Asia-Pacific Journal of Clinical Oncology
Influenza: overview on prevention and therapy
Christopher Robson, Sai Rupa Baskar, Robert Booy, Patricia E. Ferguson, Nicole M. Gilroy, Jen Kok, Indy Sandaradura, Dominic E. Dwyer · 2019 · Australian Prescriber
Maternal health in pregnancy: messages from the 2014 UK Confidential Enquiry into Maternal Death
Judy Shakespeare, Marian Knight · 2015 · British Journal of General Practice
Medicinal Attributes of American Elderberry
Andrew L. Thomas, Patrick L. Byers, P. Leszek Vincent, Wendy L. Applequist · 2020 · Medicinal and aromatic plants of the world
Avian Influenza: Recent Epidemiology, Travel-Related Risk, and Management
Rajeka Lazarus, Poh Lian Lim · 2014 · Current Infectious Disease Reports
Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2’s pathogenicity factors
Ömür Baysal, Naeem Abdul Ghafoor, Ragıp Soner Silme, Alexander N. Ignatov, Volha Kniazeva · 2021 · PLoS ONE
Chronic Pain Produces Reversible Memory Deficits That Depend on Task Difficulty in Rats
Caroline E. Phelps, Edita Navratilova, Frank Porreca · 2021 · Journal of Pain
Antivirals for influenza: where now for clinical practice and pandemic preparedness?
Jonathan S. Nguyen‐Van‐Tam, Peter Openshaw, Karl G. Nicholson · 2014 · The Lancet
Immunological considerations for developing antibody therapeutics for Influenza A
Po-Ying Chan-Hui, Kristine M. Swiderek · 2015 · Human Vaccines & Immunotherapeutics
Impact of early neuraminidase inhibitor treatment on clinical outcomes in patients with influenza B-related pneumonia: a multicenter cohort study
Liang Chen, Xiudi Han, Yanli Li, Chunxiao Zhang, Xiqian Xing · 2020 · European Journal of Clinical Microbiology & Infectious Diseases
Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown
Michael R. Rose, Kathleen Hiltz, Robert Scott Stephens, David N. Hager · 2020 · The Lancet Respiratory Medicine
A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months
Barbara A. Rath, William A. Blumentals, Mary Katherine Miller, Kathryn A. Starzyk, Bogusław Tetiurka, Martina Wollenhaupt · 2014 · Pharmacoepidemiology and Drug Safety
Latest developments in early diagnosis and specific treatment of severe influenza infection
Francisco Valenzuela-Sánchez, Blanca Valenzuela-Méndez, Juan Francisco Rodríguez Gutiérrez, Ángel Estella · 2023 · Journal of Intensive Medicine
Targeting H3N2 influenza: advancements in treatment and vaccine strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, GSN Koteswara Rao, Roja Rani Budha, Aroop Mohanty, Rachana Mehta, Vasso Apostolopoulos, Sanjit Kumar Sah, D. Katterine Bonilla‐Aldana et al. · 2024 · Expert Review of Anti-infective Therapy
How to manage antivirals in critically ill patients with influenza?
Pierre Bay, Ignacio Martín‐Loeches, Anne-Fleur Haudebourg, Minh Lê, Gilles Peytavin, Marie‐Anne Rameix‐Welti, Slim Fourati, Nicolas de Prost · 2025 · Clinical Microbiology and Infection
Use of Influenza Antivirals in Pandemic Response
Maria Cristina Fleischmann Alves Zambon, Puja R Myles, Norio Sugaya · 2025 · The Journal of Infectious Diseases
Hospital Readmissions Among Children With H1N1 Influenza Infection
Thomas V. Brogan, Matt Hall, Marion R. Sills, Evan S. Fieldston, Harold K. Simon, Michael B. Mundorff, Daniel B. Fagbuyi, Samir S. Shah · 2014 · Hospital Pediatrics
Evaluation of publication bias for 12 clinical trials of molnupiravir to treat SARS-CoV-2 infection in 13 694 patients with meta-analysis
Jack M. Lawrence, Manya Mirchandani, Andrew Martin Hill · 2022 · Journal of Antimicrobial Chemotherapy
Evaluation of the Becton Dickinson Rapid Influenza Diagnostic Tests in Outpatients in Germany during Seven Influenza Seasons
Maren Eggers, Martin Enders, Elena Terletskaia‐Ladwig · 2015 · PLoS ONE
Oseltamivir for influenza
Peter Doshi, Carl J. Heneghan, Tom Jefferson · 2015 · The Lancet
Influenza A subtype H3N2 is associated with an increased risk of hospital dissemination – an observational study over six influenza seasons
E. Rothman, Oskar Olsson, Claus Bohn Christiansen, Mattias Rööst, Malin Inghammar, U. Karlsson · 2023 · Journal of Hospital Infection
Drug resistance and possible therapeutic options against influenza A virus infection over past years
Muhammad Asif Raza, Muhammad Awais Ashraf · 2024 · Archives of Microbiology
Influenza With and Without Oseltamivir Treatment and Neuropsychiatric Events Among Children and Adolescents
James W. Antoon, Derek J. Williams, Jean Bruce, Mert Sekmen, Yuwei Zhu, Carlos Gabriel Grijalva · 2025 · JAMA Neurology
Specific Influenza Therapy: Current State and Prospects (Review)
A. I. Odnovorov, Т. В. Гребенникова, Т. В. Плетенева · 2020 · Drug development & registration
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Edris Nury, Karin Bischoff, Katharina Wollmann, Kai Nitschke, Szimonetta Lohner, Martin Christian Schumacher, Gerta Rücker, Anette Blümle · 2020 · BMC Medical Research Methodology
The Common Cold and Influenza in Children: To Treat or Not to Treat?
Natalia Anatolievna Geppe, Andrey Zaplatnikov, Elena G. Kondyurina, M.M. Chepurnaya, Natalia G. Kolosova · 2023 · Microorganisms
Race, Ethnicity, and Ancestry in Clinical Pathways: A Framework for Evaluation
Robert H. Rosen, Alexandra Epee-Bounya, Dorothy L. Curran, Sarita Chung, Robert G. Hoffmann, Lois Kaye Lee, Carolyn H. Marcus, Camila M. Mateo, Jason E. Miller, Cameron Nereim et al. · 2023 · PEDIATRICS
Post-influenza aspergillus ventriculitis
Benjamin Canning, Varuni Senanayake, Daniel S. Burns, Edward Moran, Martin J Dedicoat · 2020 · Clinical Infection in Practice
Hidden testing and selective disclosure of evidence
Claudia Herresthal · 2022 · Journal of Economic Theory
Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients
Eliane Rohner, Michael Grabik, Thomy Tonia, Peter Jüni, Frank Pétavy, Francesco Pignatti, Julia Bohlius · 2017 · PLoS ONE
Early Fever Resolution in Early Childhood Influenza Treated with Baloxavir Marboxil: A Retrospective Study Compared to Those with Oseltamivir
Keiko Nezu, Shingo Hayashida, Nobuhiko Nagano, Seiichi Udagawa, Ichiro Morioka · 2023 · Medicina
Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir
Denio Adrianus Ridjab, Ignatius Ivan, Fanny Budiman, Veronica Dwi Jani Juliawati · 2021 · Medicine
A systematic review of acute and emergency care interventions for adolescents and adults with severe acute respiratory infections including COVID-19 in low- and middle-income countries
Stephanie Chow Garbern, Pryanka Relan, Gerard Michael O’Reilly, Corey B Bills, Megan L. Schultz, Indi Trehan, Sean M Kivlehan, Torben Kim Becker · 2022 · Journal of Global Health
Passive immunotherapies for the next influenza pandemic
Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew S Pekosz, Fabrizio Maggi, Arturo Casadevall · 2024 · Reviews in Medical Virology
Safety analysis of Oseltamivir and Baloxavir Marboxil after market approval: a pharmacovigilance study based on the FDA adverse event reporting system
Yunsong Li, Xiaoling Wang, Yufang Liao, Yanbin Zeng, Wanlong Lin, Wei Zhuang · 2024 · BMC Infectious Diseases
Should we recommend neuroaminidase inhibitors for influenza?
Leonard Leibovici, Mical Paul · 2014 · Clinical Microbiology and Infection
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial
Xiao Li, Joke Bilcke, Alike W. van der Velden, Emily Bongard, Robin Bruyndonckx, Pär‐Daniel Sundvall, Nicolay Jonassen Harbin, Samuel Coenen, Nick A Francis, Pascale Bruno et al. · 2021 · Clinical Drug Investigation
On the Suppression of Medical Evidence
Alexander Christian · 2017 · Journal for General Philosophy of Science
Oseltamivir phosphate (Tamiflu) alters neurobehavior of zebrafish larvae by inducing mitochondrial dysfunction
Shuang Wang, Minjian Zou, Zhirui Zhu, Zuo Wang, Kemin Li, Jiayi Ruan, Bixi Zhao, Chen Pan, Xianyong Lan, Shengxiang Zhang et al. · 2024 · The Science of The Total Environment
Variability of Clinician Recommendations for Oseltamivir in Children Hospitalized With Influenza
Hannah K. Bassett, Suchitra Rao, Jimmy B. Beck, Patrick W. Brady, Ravi R. Jhaveri, Torsten A. Joerger, Danni Liang, Ricardo A. Quinonez, Alaina Shine, Joanna Malec et al. · 2025 · PEDIATRICS
Association between oseltamivir use and neuropsychiatric adverse events in influenza patients: a nationwide population-based cohort study
Hye‐Rim Kang, Suk‐Chan Jang, Ju‐Young Shin · 2020 · Expert Opinion on Drug Safety
Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial
Rémi Flicoteaux, Camélia Protopopescu, Annick Tibi, Thierry Blanchon, Sylvie van der Werf, Xavier Duval, Anne Mosnier, Cécile Charlois-Ou, Bruno Lina, Catherine Leport et al. · 2017 · BMJ Open
Pharmacokinetics of oseltamivir phosphate and oseltamivir carboxylate in non-pregnant and pregnant rhesus monkeys
Lucie Loukotková, Mallikarjuna Shivapura Basavarajappa, Annie Lumen, Rosemary Roberts, Donald R. Mattison, Suzanne M. Morris, Jeffrey Fisher, Frederick A. Beland, Gonçalo Gamboa da Costa · 2020 · Regulatory Toxicology and Pharmacology
From digital hype to analogue reality: Universal simulation beyond the quantum and exascale eras
Peter V. Coveney, Roger Highfield · 2020 · Journal of Computational Science
Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines
Ishmeala Rigby, Melina Michelen, Hung‐Yuan Cheng, Andrew Dagens, Dania Talaat Dahmash, Samuel Lipworth, Eli Harriss, Erhui Cai, Valeria Balan, Alexandra Oti et al. · 2022 · BMC Medicine
Systematic Reviews and Meta‐Analysis
Iain Crombie · 2021 · Wiley eBooks
Pandemic Risk Modelling
Dominic Smith · 2017 · Springer eBooks
Alternative Regimens of Neuraminidase Inhibitors for Therapy of Hospitalized Adults with Influenza: A Systematic Review of Randomized Controlled Trials
Sofía Tejada, Laura Campogiani, Candela Solé-Lleonart, Jordi Rello · 2020 · Advances in Therapy
Rapid Molecular Panels: What Is in the Best Interest of the Patient? A Review of Patient Outcome Studies for Multiplex Panels Used in Bloodstream, Respiratory, and Neurological Infections
Kaede V. Sullivan · 2017 · Clinical Microbiology Newsletter
Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness
Robin Bruyndonckx, Joke Bilcke, Alike W. van der Velden, Xiao Li, Niel Hens, Samuel Coenen, Christopher Butler, Philippe Beutels · 2021 · Value in Health
Severe viral lower respiratory tract infections in Brazilian children: Clinical features of a national cohort
Rodrigo Caldas Menezes, Isabella B. B. Ferreira, Luciana Fonseca Sobral, Stefania Lacerda Garcia, Hugo Nunes Pustilnik, Mariana Araújo‐Pereira, Bruno B. Andrade · 2023 · Journal of Infection and Public Health
A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses
Nicolas Fortin, Mathilde Hénaut, Nathalie Goyette, René Maltais, Jean‐Yves Sancéau, André Marette, Donald Poirier, Yacine Abed, Guy Boivin · 2024 · Journal of Medical Virology
Adverse events associated with oseltamivir and baloxavir marboxil in against influenza virus therapy: A pharmacovigilance study using the FAERS database
Yixia Zhou, Liuyin Jin, Xiaolong Lai, Yang Li, Lindan Sheng, Guoming Xie, Jianjiang Fang · 2024 · PLoS ONE
Therapeutic Options Against the New Coronavirus: Updated Clinical and Laboratory Evidences
Amélia Carolina Lopes Fernandes, Adson José Martins Vale, Fausto Pierdoná Gúzen, Francisco Irochima Pinheiro, Ricardo Ney Cobucci, Eduardo Pereira de Azevedo · 2020 · Frontiers in Medicine
Oseltamivir-Associated Bradycardia in Critically Ill Patients
Robert MacLaren, Janelle Francisco, Megan Fetters, Jessica L. Brady, Crystal Kim, Cameron Welker · 2021 · Annals of Pharmacotherapy
COVID-19 can be called a treatable disease only after we have antivirals
Xueyang Zhang, Peter Horby, Bin Cao · 2022 · 中国科学通报：英文版
System dynamic modelling of healthcare associated influenza -a tool for infection control
Martina Sansone, Paul Holmström, Stefan Hallberg, Rickard Nordén, Lars‐Magnus Andersson, Johan Westin · 2022 · BMC Health Services Research
Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect
Barbara J. Mintzes, Joel Lexchin, Ancel.la Santos · 2015 · British Medical Bulletin
An Instant Update on Viruses
Uwe Karsten Simon · 2021 · The American Biology Teacher
Severe influenza A in a Tunisian ICU sentinel SARI centre: Epidemiological and clinical features
Amira Jamoussi, Samia Ayed, Takoua Merhabene, Hamdi Doghri, Jalila Ben Khelil, Mohamed Besbes · 2022 · PLoS ONE